TSS
CRNX icon

Two Sigma Securities’s Crinetics Pharmaceuticals CRNX Stock Holding History

Two Sigma Securities’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,164
Closed -$264K – 1495
2025
Q2 		$264K Buy
+9,164
New +$283K 0.03% 751
2024
Q2 		– Sell
-7,841
Closed -$367K – 3089
2024
Q1 		$367K Buy
+7,841
New +$307K ﹤0.01% 1799

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Two Sigma Securities's CRNX Position: Q3 2025 in Review

Two Sigma Securities sold out of Crinetics Pharmaceuticals (CRNX) in Q3 2025, closing a stake of 9,164 shares — an estimated $264K sold.

Two Sigma Securities first reported a position in CRNX in Q1 2024 and held it in 2 quarters. The position peaked at $367K in Q1 2024. 225 funds tracked by Wall St. Rank hold CRNX as of Q3 2025.

  • Two Sigma Securities reported no remaining Crinetics Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 9,164 Crinetics Pharmaceuticals shares in Q3 2025, an estimated $264K.
  • Two Sigma Securities first reported a position in Crinetics Pharmaceuticals in Q1 2024 and held it in 2 quarters.
  • Two Sigma Securities's Crinetics Pharmaceuticals position peaked at $367K in Q1 2024.
  • 225 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.